Tuberculosis
Relevant Pages
HIV - Special Considerations and Clinical Management of HIV-Infected Drug Users
HIV - Tuberculosis and Other Mycobacterial Infections
- Introduction
- Transmission of Tuberculosis
- Clinical Presentation of Active Tuberculosis
- Diagnosis of Nontuberculous Mycobacteria
- Immune Reconstitution Inflammatory Syndrome
- Epidemiology of Tuberculosis
- Treatment of Tuberculosis in Children
- Diagnosis of Tuberculosis
- Treatment of Tuberculosis in Adults
- Prevention/Prophylaxis
- Antiretroviral Therapy During Tuberculosis Treatment
- Latent Tuberculosis Infection
HIV - The Approach to the HIV-Infected Patient With Specific Symptom Complexes/Common Presentations
- Fever of Unknown Origin: Etiology and Diagnostic Approach
- Pulmonary Manifestations: Etiology and Diagnostic Approach
- Diseases due to Comorbidities
- Relationship Among Specific Opportunistic Infections and CD4+ Cell Counts
- Geographic Variance in Occurrence of Opportunistic Infections
- Presentations of Opportunistic Infections in the Current Era of Antiretroviral Therapy
- Abdominal Pain, Nausea, and Vomiting
- Diarrhea
HIV - Management of IRIS
- Considerations for Resource-Limited Settings
- Prevention/Prophylaxis of IRIS
- Etiology/Pathogenesis
- Treatment
- Diagnosis and Monitoring
- IRIS Associated With Tuberculosis
- ART Initiation and IRIS in Patients With Tuberculosis
HIV - Primary Care for HIV-Infected Patients in Resource-Limited Settings
HIV - Management of Neurologic Diseases
HIV - Management of Children With or Exposed to HIV
HIV - Primary Care of the Newly Diagnosed HIV-Infected Patient in Developed Countries
HIV - Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
HIV - Key Pharmacologic Principles and Drug-Drug Interactions in HIV Patient Care
HIV - Optimizing Adherence to Antiretroviral Therapy
Guidelines
- British HIV Association Guidelines for the Treatment of HIV-1-Positive Adults With Antiretroviral Therapy
- British HIV Association Guidelines for the Treatment of TB/HIV Coinfection
- Clinical Practice Guidelines for <i>Clostridium difficile</i> Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach - Second Edition
- Essential Prevention and Care Interventions for Adults and Adolescents Living With HIV in Resource-Limited Settings
- Guidelines for HIV Surveillance Among Tuberculosis Patients
- Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV
- Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings
- Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
- Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
- Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach.
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
- Treatment of Tuberculosis
- Update: Adverse Event Data and Revised Recommendations Against Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection
- Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection-United States, 2010